News

Waymo in talks to raise funds at $100bn valuation

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Waymo, the

News

Editor's Top Picks

Ark Restaurants Corp. (ARKR) Q4 2025 Earnings Call Transcript

Operator Greetings, and welcome to Ark Restaurants Fourth Quarter and Year-End 2025 Results Call. . As a reminder, this conference

News

Your one-stop resource for personal news and tips.

Join our newsletter to get the latest news directly to your inbox.

More form News

Twin Disc: Strong FCF And Electric Solutions Could Push The Price Up (NASDAQ:TWIN)

Twin Disc (NASDAQ:TWIN) recently reaffirmed its medium-term targets, including future gross margin close to 30%

DNA results confirm Yevgeny Prigozhin’s death, Moscow says

Receive free Yevgeny Prigozhin updatesWe’ll send you a myFT Daily Digest email rounding up the

Exelixis: Positive Pancreatic Cancer Data Brings Two Big Catalysts On Deck (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) has made great progress in advancing its drug known as CABOMETYX for the

Week In Review: A Consortium Of China Drug Distributors Want To Acquire Poland’s Neuca

Deals and Financings China’s drug distributors are in the hunt to acquire Poland’s Neuca, a

Exciting lighting: unusual table lamps

Receive free Interiors updatesWe’ll send you a myFT Daily Digest email rounding up the latest

Long Thesis On British American Tobacco Amid Current Tobacco Industry Backdrop (NYSE:BTI)

Editor's note: Seeking Alpha is proud to welcome X's Industry Analysis as a new contributor.

Zimbabwe president re-elected after vote criticised for irregularities

Receive free Zimbabwe updatesWe’ll send you a myFT Daily Digest email rounding up the latest

Curaleaf Could Fall To $2 (OTCMKTS:CURLF)

I was very lucky with the timing on my last article on Curaleaf (OTCPK:CURLF), when

Xeris Biopharma’s Financial Pathway: Growth Amid Challenges (NASDAQ:XERS)

Introduction Xeris Biopharma (NASDAQ:XERS), a biopharmaceutical firm, focuses on enhancing patient lives with innovative therapies.

Carlyle Secured Lending: Slowing Growth And Challenging Fundamentals Could Hurt Returns

After experiencing whopping returns in the past few years, shareholders of Carlyle Secured Lending Inc.

Monroe Capital: The 13.5% Yield Is Safer But NAV Is Still Falling (NASDAQ:MRCC)

Monroe Capital (NASDAQ:MRCC) last declared a quarterly cash dividend of $0.25 per share, in line

Power-starved North Korea turns to solar energy to keep the lights on

Receive free North Korea updatesWe’ll send you a myFT Daily Digest email rounding up the

Crown Castle Vs. American Tower: Only One Deserves To Be Called King (NYSE:CCI)

For better or worse, I have, over the years, found myself drawn to companies that

Vivid Seats: Taylor Swift Tours, Digital Marketing Improvements Imply Undervaluation. (NASDAQ:SEAT)

Vivid Seats Inc. (NASDAQ:SEAT) delivered quarterly market place orders growth, and offered a guidance increase.

Carvana Stock: It Is Not That Simple (NYSE:CVNA)

Carvana Co. (NYSE:CVNA) is a $7.5-billion market cap Arizona-based firm that operates a US e-commerce